mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.02 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.03 |
mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
0.03 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.04 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.04 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.05 |
mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.05 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
0.05 |